| Infection Control Today

|Articles|August 12, 2002 (Updated: November 14, 2020)

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Subscribe Now!

Related Content

3D Illustration of Candida Fungi: Human Pathogenic Yeasts Including Candida Albicans and C Auris (Adobe Stock 1208974553 by ProArt Studios with AI)

Hospital-Onset Bacteremia in Burn Patients May Be a Poor Quality Metric, Study Finds

ByTori Whitacre Martonicz, MA

March 5th 2026

3D microscopic fungal cells and hyphae network, medical infection background (Adobe Stock 1839119128 by Philipp with AI)

Why Antifungal Drug Development Remains So Challenging According to John Rex, MD

ByTori Whitacre Martonicz, MA

Published: March 5th 2026 | Updated: March 5th 2026

Cleaning systems for medical instruments. Ultrasonic cleaner (Adobe Stock 136854229 By flywish)

Ultrasonic Cleaning Is Not a Machine; It Is a Quality System: Preventing Hidden Bioburden in Surgical Instruments

ByMarjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB

March 4th 2026

A series of illustrations demonstrating the body’s immune response to sepsis (Adobe Stock 805248810 by Tee with AI)

Precision Immunotherapy Shows Promise for Improving Organ Dysfunction in Sepsis

ByTori Whitacre Martonicz, MA

March 4th 2026

DNA structure and HIV-infected, blue background (Adobe Stock 149600914 by Giovanni Cancemi)

Beyond Viral Suppression: Next-Generation HIV Therapeutics Target Reservoirs, Broadly Neutralizing Antibodies, and Gene Editing

ByKersten Kurt Koelsch, MD

March 4th 2026

Newsletter

Related Content

Hospital-Onset Bacteremia in Burn Patients May Be a Poor Quality Metric, Study Finds

Why Antifungal Drug Development Remains So Challenging According to John Rex, MD

Ultrasonic Cleaning Is Not a Machine; It Is a Quality System: Preventing Hidden Bioburden in Surgical Instruments

Precision Immunotherapy Shows Promise for Improving Organ Dysfunction in Sepsis

Beyond Viral Suppression: Next-Generation HIV Therapeutics Target Reservoirs, Broadly Neutralizing Antibodies, and Gene Editing

Trending on Infection Control Today

Why Antifungal Drug Development Remains So Challenging According to John Rex, MD

Beyond Viral Suppression: Next-Generation HIV Therapeutics Target Reservoirs, Broadly Neutralizing Antibodies, and Gene Editing

Inside Disinfectant R&D: What Infection Preventionists Need to Know About Efficacy, Safety, and Real-World Performance

Turning Sterile Processing into a Strategic Infection Prevention Asset

Hospital-Onset Bacteremia in Burn Patients May Be a Poor Quality Metric, Study Finds